Impact of topical moxifloxacin prophylaxis and povidone iodine on conjunctival bacterial flora in patients receiving intravitreal injections in a tertiary healthcare center in India

CONCLUSION: We could not establish any additional benefits of topical moxifloxacin prophylaxis with regard to a reduction in conjunctival flora when compared with PVI 5%. PVI can be used as an efficient monotherapy in patients undergoing repeated IVI.PMID:36387728 | PMC:PMC9648245 | DOI:10.4103/jfmpc.jfmpc_928_21
Source: Primary Care - Category: Primary Care Authors: Source Type: research